Literature DB >> 35460387

Left atrial deformation indices in β-thalassemia major patients.

Dimitrios Patsourakos1, Constantina Aggeli2, Konstantinos A Gatzoulis2, Sophia Delicou3, Yannis Dimitroglou2, Katerina Xydaki3, Christina Fragodimitri4, Aristeidis Androulakis5, Konstantinos Tsioufis2.   

Abstract

The presence of atrial cardiomyopathy in β-thalassemia major (β-TM) patients complicates their clinical condition. The diagnosis is challenging even with cardiac magnetic resonance (CMR) imaging. Novel echocardiographic techniques are applied to increase the diagnostic yield. Fifty-six β-TM patients and thirty age and sex-matched controls were included in the present cross-sectional study. Heart rate, PR duration, and P axis were measured by electrocardiography, left ventricular ejection fraction (LVEF) and end-diastolic diameter (LVEDD), ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/e'), left atrial volume index (LAVI), left atrial strain at reservoir (LASr), conduit (LAScd) and contraction (LASct) phases respectively, left ventricular global longitudinal strain (GLS) by echocardiography, and T2* calculation in patient group by CMR. PR duration, LVEF, LAVI, E/e', GLS, and left atrial deformation parameters differed between patients and controls (p <0.05). In patient group, left atrial strain was correlated with PR duration, LAVI, E/e', GLS, and T2* (p <0.05). T2* was correlated only with left atrial deformation indices (p <0.05). Patients with a history of atrial fibrillation were older, had lower heart rate, prolonged PR, increased E/e' and LAVI, and impaired left atrial strain (p <0.05). LASct differed relative to the presence of atrial fibrillation and myocardial iron overload. Atrial strain could be of clinical use in the early detection of atrial cardiomyopathy. An impaired LASct could identify β-TM patients with undetected episodes of atrial fibrillation. Finally, left atrial strain may be helpful in myocardial iron load estimation.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Atrial fibrillation; Beta-thalassemia; Echocardiography; Magnetic resonance imaging; Speckle tracking

Mesh:

Year:  2022        PMID: 35460387     DOI: 10.1007/s00277-022-04842-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  24 in total

1.  Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia major.

Authors:  Walter Li; Thomas Coates; John C Wood
Journal:  Haematologica       Date:  2008-02       Impact factor: 9.941

2.  Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging.

Authors:  Jens-Uwe Voigt; Gianni Pedrizzetti; Peter Lysyansky; Tom H Marwick; Hélène Houle; Rolf Baumann; Stefano Pedri; Yasuhiro Ito; Yasuhiko Abe; Stephen Metz; Joo Hyun Song; Jamie Hamilton; Partho P Sengupta; Theodore J Kolias; Jan d'Hooge; Gerard P Aurigemma; James D Thomas; Luigi Paolo Badano
Journal:  J Am Soc Echocardiogr       Date:  2015-02       Impact factor: 5.251

3.  Prevalence and predictors of cardiac and liver iron overload in patients with thalassemia: A multicenter study based on real-world data.

Authors:  Rungroj Krittayaphong; Vip Viprakasit; Pairash Saiviroonporn; Noppadol Siritanaratkul; Suvipaporn Siripornpitak; Arunotai Meekaewkunchorn; Thawatchai Kirawittaya; Pornpun Sripornsawan; Arunee Jetsrisuparb; Jiraporn Srinakarin; Peerapon Wong; Nuttaporntira Phalakornkul; Phakatip Sinlapamongkolkul; John Wood
Journal:  Blood Cells Mol Dis       Date:  2017-08-05       Impact factor: 3.039

Review 4.  Thalassaemia.

Authors:  Douglas R Higgs; James Douglas Engel; George Stamatoyannopoulos
Journal:  Lancet       Date:  2011-09-09       Impact factor: 79.321

Review 5.  Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?

Authors:  Karn Wijarnpreecha; Sirinart Kumfu; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Hemoglobin       Date:  2015-01-09       Impact factor: 0.849

6.  The pathophysiological relationship and clinical significance of left atrial function and left ventricular diastolic dysfunction in β-thalassemia major.

Authors:  Anna G Kostopoulou; Dimitrios P Tsiapras; Antigoni S Chaidaroglou; Dimitrios E De Giannis; Dimitrios Farmakis; Dimitrios Th Kremastinos
Journal:  Am J Hematol       Date:  2013-09-19       Impact factor: 10.047

7.  Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major.

Authors:  P Kirk; M Roughton; J B Porter; J M Walker; M A Tanner; J Patel; D Wu; J Taylor; M A Westwood; L J Anderson; D J Pennell
Journal:  Circulation       Date:  2009-10-02       Impact factor: 29.690

8.  The effect of iron chelation therapy on overall survival in sickle cell disease and β-thalassemia: A systematic review.

Authors:  Samir K Ballas; Amer M Zeidan; Vu H Duong; Michelle DeVeaux; Matthew M Heeney
Journal:  Am J Hematol       Date:  2018-04-28       Impact factor: 10.047

Review 9.  World distribution, population genetics, and health burden of the hemoglobinopathies.

Authors:  Thomas N Williams; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

Review 10.  Cardiac T2 * mapping: Techniques and clinical applications.

Authors:  Pandji Triadyaksa; Matthijs Oudkerk; Paul E Sijens
Journal:  J Magn Reson Imaging       Date:  2019-12-14       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.